new glp-1 drugs in development based medicines for emerging therapies Pharma Giants Bet on Next-Generation

(Receptor localization and emesis circuit mechanism.) Hay DL, Christopoulos G, Christopoulos A, Sexton PM

Faux, N

May help with Parkinson's disease: Clinical studies show that glutathione has the ability to improve motor function in patients with Parkinson's disease

But what is particularly intriguing is to combine this intervention with a drug that knocks down the self-directed T-cell effect and significantly delayed the onset of Type 1 diabetes with such drugs as teplizumab shown effective in a small trial of at-risk relatives

For example, a number of large-scale clinical trials have demonstrated that GLP-1RA could reduce the risk of cardiovascular events, which has been well reviewed in elsewhere (83, 84) and we will not further discuss here

Li YF, Tseng PJ, Lin CC, Hung CL, Lin SC, Su WC, et al